Tampa, Fla. – In response to new research that found BMPEA1 (an amphetamine-like substance) in weight-loss and athletic performance substances, the OAC is urging the Food and Drug Administration (FDA) to further evaluate the safety and efficacy of these supplements. “As Americans, we rely on the FDA to be the inherent watchdogs of certain things,
Read Article